» Articles » PMID: 19487684

Distinct Conformations of in Vitro and in Vivo Amyloids of Huntingtin-exon1 Show Different Cytotoxicity

Overview
Specialty Science
Date 2009 Jun 3
PMID 19487684
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

A hallmark of polyglutamine diseases, including Huntington disease (HD), is the formation of beta-sheet-rich aggregates, called amyloid, of causative proteins with expanded polyglutamines. However, it has remained unclear whether the polyglutamine amyloid is a direct cause or simply a secondary manifestation of the pathology. Here we show that huntingtin-exon1 (thtt) with expanded polyglutamines remarkably misfolds into distinct amyloid conformations under different temperatures, such as 4 degrees C and 37 degrees C. The 4 degrees C amyloid has loop/turn structures together with mostly beta-sheets, including exposed polyglutamines, whereas the 37 degrees C amyloid has more extended and buried beta-sheets. By developing a method to efficiently introduce amyloid into mammalian cells, we found that the formation of the 4 degrees C amyloid led to substantial toxicity, whereas the toxic effects of the 37 degrees C amyloid were very small. Importantly, thtt amyloids in different brain regions of HD mice also had distinct conformations. The thermolabile thtt amyloid with loop/turn structures in the striatum showed higher toxicity, whereas the rigid thtt amyloid with more extended beta-sheets in the hippocampus and cerebellum had only mild toxic effects. These studies show that the thtt protein with expanded polyglutamines can misfold into distinct amyloid conformations and, depending on the conformations, the amyloids can be either toxic or nontoxic. Thus, the amyloid conformation of thtt may be a critical determinant of cytotoxicity in HD.

Citing Articles

Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease.

Bagherpoor Helabad M, Matlahov I, Kumar R, Daldrop J, Jain G, Weingarth M Nat Commun. 2024; 15(1):10793.

PMID: 39737997 PMC: 11686214. DOI: 10.1038/s41467-024-55062-8.


Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation.

van der Wel P Biochem Soc Trans. 2024; 52(2):719-731.

PMID: 38563485 PMC: 11088915. DOI: 10.1042/BST20230731.


The polyglutamine domain is the primary driver of seeding in huntingtin aggregation.

Skeens A, Siriwardhana C, Massinople S, Wunder M, Ellis Z, Keith K PLoS One. 2024; 19(3):e0298323.

PMID: 38483973 PMC: 10939245. DOI: 10.1371/journal.pone.0298323.


Gene-dosage- and sex-dependent differences in the prodromal-Like phase of the F344tgHD rat model for Huntington disease.

Ratz-Wirsching V, Habermeyer J, Moceri S, Harrer J, Schmitz C, von Horsten S Front Neurosci. 2024; 18:1354977.

PMID: 38384482 PMC: 10879377. DOI: 10.3389/fnins.2024.1354977.


Fluorescent protein tagging promotes phase separation and alters the aggregation pathway of huntingtin exon-1.

Pandey N, Varkey J, Ajayan A, George G, Chen J, Langen R J Biol Chem. 2023; 300(1):105585.

PMID: 38141760 PMC: 10825056. DOI: 10.1016/j.jbc.2023.105585.


References
1.
Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G . Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 1995; 378(6555):403-6. DOI: 10.1038/378403a0. View

2.
Shorter J, Lindquist S . Prions as adaptive conduits of memory and inheritance. Nat Rev Genet. 2005; 6(6):435-50. DOI: 10.1038/nrg1616. View

3.
Ordway J, Gutekunst C, Bernstein E, Cearley J, Wiener H, Dure 4th L . Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell. 1997; 91(6):753-63. DOI: 10.1016/s0092-8674(00)80464-x. View

4.
Chien P, Weissman J, DePace A . Emerging principles of conformation-based prion inheritance. Annu Rev Biochem. 2004; 73:617-56. DOI: 10.1146/annurev.biochem.72.121801.161837. View

5.
Bates G . Huntingtin aggregation and toxicity in Huntington's disease. Lancet. 2003; 361(9369):1642-4. DOI: 10.1016/S0140-6736(03)13304-1. View